Antithrombotic therapy in high-risk pregnancy (Q34045053)

30 July 2017

1 reference

title

Antithrombotic therapy in high-risk pregnancy (English)

1 reference

30 July 2017

0 references

Heilmann L

1

1 reference

30 July 2017

Schneider DM

series ordinal

2

1 reference

30 July 2017

von Tempelhoff GF

series ordinal

3

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1133-50, ix

1 reference

Pregnancy and venous thrombo-embolism

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Antiphospholipid antibodies in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Thrombophilia and fetal loss

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

HELLP syndrome associated with factor V R506Q mutation

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Development of resistance to activated protein C during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

The factor V Leiden mutation may predispose women to severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Anticoagulation of women with prosthetic heart valves during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Inherited thrombophilia and pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Thrombosis prophylaxis in obstetrics and gynaecology.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

[Prevention of thromboembolism with low-molecular weight heparin in pregnancy]

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Long-term therapy with subcutaneous heparin during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Activated protein C resistance and Factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Preeclampsia is associated with a reduced response to activated protein C

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Lupus anticoagulant and pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Prevention of thromboembolism in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Second-trimester pregnancy loss is associated with activated C resistance

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Venous thromboembolism during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

Risk of thrombosis during pregnancy and post-partum in hereditary thrombophilia

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70175-1

7 January 2021

10.1016/S0889-8588(05)70175-1

Identifiers

DOI

1 reference

30 July 2017

1 reference